Kristin Abate

Insider Reports History

Location
Newton, MA
Signature
/s/ Nancy Smith as Attorney-in-Fact for Kristin Abate
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristin Abate:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. Chief Accounting Officer Common Stock 22,622 $159,032 $7.03 28 Jan 2026 Direct
Karyopharm Therapeutics Inc. Chief Accounting Officer Stock Option (right to buy) 1,866 28 Feb 2025 Direct

Insider Reports Filed by Kristin Abate

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 27 Jan 2026 2 -$352 4 Chief Accounting Officer 29 Jan 2026, 16:57
KPTI Karyopharm Therapeutics Inc. 21 Jan 2026 1 -$1,579 4 Chief Accounting Officer 22 Jan 2026, 16:09
KPTI Karyopharm Therapeutics Inc. 15 Oct 2025 1 $0 4 Chief Accounting Officer 16 Oct 2025, 16:33
KPTI Karyopharm Therapeutics Inc. 01 Oct 2025 1 -$2,279 4 Chief Accounting Officer 03 Oct 2025, 16:56
KPTI Karyopharm Therapeutics Inc. 12 Sep 2025 2 -$148 4 Chief Accounting Officer 16 Sep 2025, 16:30
KPTI Karyopharm Therapeutics Inc. 03 Sep 2025 1 -$81.36 4 Chief Accounting Officer 04 Sep 2025, 16:53
KPTI Karyopharm Therapeutics Inc. 22 Jul 2025 1 -$952 4 Chief Accounting Officer 23 Jul 2025, 17:18
KPTI Karyopharm Therapeutics Inc. 04 Mar 2025 1 -$3,592 4 Chief Accounting Officer 06 Mar 2025, 16:15
KPTI Karyopharm Therapeutics Inc. 28 Feb 2025 2 $0 4 Chief Accounting Officer 04 Mar 2025, 16:49
KPTI Karyopharm Therapeutics Inc. 06 Nov 2024 0 $0 3 Chief Accounting Officer 22 Nov 2024, 16:01